These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10477745)

  • 1. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII.
    Freeman BJ; Roberts MS; Vogler CA; Nicholes A; Hofling AA; Sands MS
    Blood; 1999 Sep; 94(6):2142-50. PubMed ID: 10477745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS; Erway LC; Vogler C; Sly WS; Birkenmeier EH
    Blood; 1995 Sep; 86(5):2033-40. PubMed ID: 7655032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages.
    Ohashi T; Yokoo T; Iizuka S; Kobayashi H; Sly WS; Eto Y
    Blood; 2000 Jun; 95(11):3631-3. PubMed ID: 10828055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency.
    Soper BW; Lessard MD; Vogler CA; Levy B; Beamer WG; Sly WS; Barker JE
    Blood; 2001 Mar; 97(5):1498-504. PubMed ID: 11222399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
    J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.
    Sands MS; Vogler C; Torrey A; Levy B; Gwynn B; Grubb J; Sly WS; Birkenmeier EH
    J Clin Invest; 1997 Apr; 99(7):1596-605. PubMed ID: 9120003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice.
    Poorthuis BJ; Romme AE; Willemsen R; Wagemaker G
    Pediatr Res; 1994 Aug; 36(2):187-93. PubMed ID: 7970933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Wolfe JH; Birkenmeier EH; Barker JE; Vogler C; Sly WS; Okuyama T; Freeman B; Nicholes A; Muzyczka N; Chang PL; Axelrod HR
    Neuromuscul Disord; 1997 Jul; 7(5):352-60. PubMed ID: 9267850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells.
    Maréchal V; Naffakh N; Danos O; Heard JM
    Blood; 1993 Aug; 82(4):1358-65. PubMed ID: 8353294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
    Sakurai K; Iizuka S; Shen JS; Meng XL; Mori T; Umezawa A; Ohashi T; Eto Y
    Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplanted ER-MP12hi20-58med/hi myeloid progenitors produce resident macrophages from marrow that are therapeutic for lysosomal storage disease.
    Soper BW; Duffy TM; Lessard MD; Jude CD; Schuldt AJ; Vogler CA; Levy B; Barker JE
    Blood Cells Mol Dis; 2004; 32(1):199-213. PubMed ID: 14757436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs.
    Casal ML; Wolfe JH
    Blood; 2001 Mar; 97(6):1625-34. PubMed ID: 11238101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
    Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
    Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ; Bastedo L; Maier SA; Sands MS; Chang PL
    Hum Gene Ther; 2000 Oct; 11(15):2117-27. PubMed ID: 11044913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL; Pyragius CE; Kaidonis XM; Jackson MR; Anson DS; Byers S
    Hum Gene Ther; 2014 Sep; 25(9):798-810. PubMed ID: 25003807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation.
    Birkenmeier EH; Barker JE; Vogler CA; Kyle JW; Sly WS; Gwynn B; Levy B; Pegors C
    Blood; 1991 Dec; 78(11):3081-92. PubMed ID: 1954394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
    Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy/cell therapy for lysosomal storage disease.
    Eto Y; Ohashi T
    J Inherit Metab Dis; 2000 May; 23(3):293-8. PubMed ID: 10863945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.